Pfizer and BioNTech asked the Food and Drug Administration Friday for full approval of the companies' Covid-19 vaccine. If approved, it would be the first Covid-19 vaccine in the United States to hold that distinction. The vaccine was the first to be granted an emergency use authorization in December for use in the U.S. Full approval could make vaccination mandates more widespread. |
No comments:
Post a Comment